Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 6
2014 2
2015 3
2016 3
2020 6
2021 3
2022 5
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. Horwitz SM, et al. Among authors: rozati s. J Natl Compr Canc Netw. 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015. J Natl Compr Canc Netw. 2022. PMID: 35276674
Advanced Mycosis Fungoides.
Maredia H, Rozati S. Maredia H, et al. Among authors: rozati s. N Engl J Med. 2020 Apr 2;382(14):e27. doi: 10.1056/NEJMicm1911156. N Engl J Med. 2020. PMID: 32242361 No abstract available.
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Nichakawade TD, Ge J, Mog BJ, Lee BS, Pearlman AH, Hwang MS, DiNapoli SR, Wyhs N, Marcou N, Glavaris S, Konig MF, Gabelli SB, Watson E, Sterling C, Wagner-Johnston N, Rozati S, Swinnen L, Fuchs E, Pardoll DM, Gabrielson K, Papadopoulos N, Bettegowda C, Kinzler KW, Zhou S, Sur S, Vogelstein B, Paul S. Nichakawade TD, et al. Among authors: rozati s. Nature. 2024 Apr;628(8007):416-423. doi: 10.1038/s41586-024-07233-2. Epub 2024 Mar 27. Nature. 2024. PMID: 38538786
Update on Biology of Cutaneous T-Cell Lymphoma.
Phyo ZH, Shanbhag S, Rozati S. Phyo ZH, et al. Among authors: rozati s. Front Oncol. 2020 May 12;10:765. doi: 10.3389/fonc.2020.00765. eCollection 2020. Front Oncol. 2020. PMID: 32477957 Free PMC article. Review.
Basal cell carcinoma: a paradigm for targeted therapies.
Dreier J, Felderer L, Barysch M, Rozati S, Dummer R. Dreier J, et al. Among authors: rozati s. Expert Opin Pharmacother. 2013 Jul;14(10):1307-18. doi: 10.1517/14656566.2013.798644. Epub 2013 May 8. Expert Opin Pharmacother. 2013. PMID: 23656611 Free article. Review.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H. Horwitz SM, et al. Among authors: rozati s. J Natl Compr Canc Netw. 2020 Nov 2;18(11):1460-1467. doi: 10.6004/jnccn.2020.0053. J Natl Compr Canc Netw. 2020. PMID: 33152703
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Guenova E, Hoetzenecker W, Rozati S, Levesque MP, Dummer R, Cozzio A. Guenova E, et al. Among authors: rozati s. Expert Opin Investig Drugs. 2014 Apr;23(4):457-67. doi: 10.1517/13543784.2014.876407. Epub 2014 Jan 8. Expert Opin Investig Drugs. 2014. PMID: 24397291 Review.
32 results